Voluntary announcement - purchase of shares by the trustee for the purpose of the 2022 rsu scheme
Filed with HKEX · Stock code 6855 ·
6ix hasn’t read this filing yet.
View original source (HKEXnews)Company analysis
Earlier from Ascentage Pharma Group International
- Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
- CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
- Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer
- Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026